MYX — Mayne Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Mayne Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2020 June 30th	2021 June 30th	C2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	138	98	96.7	220	149
Net Total Accounts Receivable
Net Total Receivables	233	191	282	210	208
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	491	417	512	554	461
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	238	222	226	51.5	53.3
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,825	1,463	1,288	1,247	1,143
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	219	223	629	311	314
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	788	695	742	613	689
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,038	768	546	634	454
Total Liabilities & Shareholders' Equity	1,825	1,463	1,288	1,247	1,143
Total Common Shares Outstanding